Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“ELCC25 saves the best for last!!
Day 4 with two cutting-edge sessions focusing on IO resistance and next generation ADCs. Happy to discuss the role of ADCs in oncogene-addicted NSC among bright colleagues and friends.”
More posts featuring Giannis Mountzios.
